Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Why choose index funds over active funds? Because broad diversification, lower costs, and proven long-term results often beat active management.
26,956 articlesA leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Income-focused investors are turning to monthly dividend ETFs yielding strong cash flow in 2026. Four funds stand out...
Explore two powerful growth stories that fit the idea of brilliant growth stocks hold for the long term. NVIDIA leads...
Geopolitics can push oil to $100 a barrel, but certain pipeline stocks thrive on throughput rather than price. Learn ...
Kohl's stunned investors with a strong swing in its latest quarterly results, sending the stock higher by double digi...
Fans dream of owning a piece of their favorite team. When a high-profile artist says they want a real stake rather th...
I once believed SpaceX would be a slam-dunk winner for investors. Then I realized a careful, staged approach beats ri...
In 2025, 50 donors gave a combined $22.4 billion to charity, up 35% from 2024 inflation-adjusted totals. Bill Gates r...
As 2026 unfolds, a value-led rotation is drawing fresh money into the Vanguard Value ETF (VTV). With inflation coolin...
Two flagship crypto ETFs from BlackRock pit Ethereum’s usage thesis against Bitcoin’s scarcity thesis. Here’s how IBI...
Newly listed THYP and BHYP tracking Hyperliquid's HYPE token post unusual first-week momentum, with sizable inflows a...
A volatile week left crypto ETFs in the red while a memory-chip ETF seized the spotlight, signaling a shift in invest...